Shopping Cart
- Remove All
Your shopping cart is currently empty
RIPA-56 is an inhibitor of RIP1

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $32 | In Stock | |
| 10 mg | $48 | In Stock | |
| 25 mg | $86 | In Stock | |
| 50 mg | $138 | In Stock | |
| 100 mg | $225 | In Stock | |
| 200 mg | $333 | In Stock | |
| 500 mg | $559 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $50 | In Stock |
| Description | RIPA-56 is an inhibitor of RIP1 |
| Targets&IC50 | RIP1:13 nM |
| In vivo | In the SIRS mice disease model, RIPA-56?efficiently reduced tumor necrosis factor alpha (TNFα)-induced mortality and multi-organ damage.?Compared to known RIP1 inhibitors, RIPA-56?is potent in both human and murine cells, is much more stable in vivo, and is efficacious in animal model?studies. |
| Molecular Weight | 221.3 |
| Formula | C13H19NO2 |
| Cas No. | 1956370-21-0 |
| Smiles | CCC(C)(C)C(=O)N(O)Cc1ccccc1 |
| Relative Density. | 1.070 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (451.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (18.08 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.